FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileMonash IVF Group Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
MVF.AX
Monash IVF Group Limited Stock AnalysisComprehensive stock analysis for Monash IVF Group Limited (MVF.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMVF.AX
MVF.AX
Monash IVF Group Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
MVF.AX
  1. Home
  2. Stocks
  3. Monash IVF Group Limited

Monash IVF Group Limited

🇦🇺MVF.AX•ASX

Monash IVF Group Limited

🇦🇺MVF.AX•ASX
P/E ratio
38.74

Your view on MVF.AX

P/E
38.74
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Monash IVF Group Limited

Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Victoria Atkinson Afracma Fracs Mbbs
Headquarters
Pelaco Building 1, Richmond, VIC, AU
Industry
Medical - Diagnostics & Research
Sector
Healthcare
CEO
Victoria Atkinson Afracma Fracs Mbbs
Headquarters
Pelaco Building 1, Richmond, VIC, AU
Description

Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care.

This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Monash IVF Group Limited from FRC's valuation model, read against the market price. MVF.AX last traded at AUD 0.69, 38.7× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Monash IVF Group Limited. Starting points for Monash IVF Group Limited: P/E 38.7, EPS AUD 0.02, beta 0.38 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Monash IVF Group Limited. Monash IVF Group Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Monash IVF Group Limited. Trailing twelve-month EPS for Monash IVF Group Limited stands at AUD 0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 0.00AUD 0.03AUD 0.05AUD 0.05
Lowest estimateAUD 0.00AUD 0.03AUD 0.04AUD 0.05
Highest estimateAUD 0.00AUD 0.03AUD 0.05AUD 0.06
Number of analysts0155
A year agoAUD 0.02AUD 0.03AUD 0.021—
Growth vs a year ago−100.0%−22.8%——

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterSep 2025Next quarterDec 2025This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 134.84MAUD 127.47MAUD 280.80MAUD 293.62M
Lowest estimateAUD 134.84MAUD 127.47MAUD 275.97MAUD 283.72M
Highest estimateAUD 134.84MAUD 127.47MAUD 284.93MAUD 301.31M
Number of analysts2177
A year agoAUD 91.32MAUD 110.27MAUD 269.46M—
Growth vs a year ago+47.7%+15.6%+4.2%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Monash IVF Group Limited. Monash IVF Group Limited has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold MVF.AX20 companies · 5 funds
Compare MVF.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
ACL.AXAustralian Clinical Labs LimitedHealthcareMedical - Diagnostics & Research—
BDX.AXBCAL Diagnostics LimitedHealthcareMedical - Diagnostics & Research—
GSS.AXGenetic Signatures LimitedHealthcareMedical - Diagnostics & Research—
HLS.AXHealius LimitedHealthcareMedical - Diagnostics & Research—
HMD.AXHeraMED LimitedHealthcareMedical - Devices—
IDX.AXIntegral Diagnostics LimitedHealthcareMedical - Diagnostics & Research—
IIQ.AXINOVIQ LtdHealthcareMedical - Diagnostics & Research—
IME.AXImExHS LimitedHealthcareMedical - Diagnostics & Research—
More Medical - Diagnostics & Research companies
TickerTypeCompanySectorExchangeMkt cap
WGSGeneDx Holdings Corp.HealthcareNASDAQ$1.6B
WUXAYWuXi AppTec Co., Ltd.HealthcareOTC$45.6B
WUXIFWuXi AppTec Co., Ltd.HealthcareOTC$39.8B
XGNExagen Inc.HealthcareNASDAQ$99.5M
SKHHYSonic Healthcare LimitedHealthcareOTC$8.2B
SLDXStella Diagnostics Inc.HealthcareOTC$1.4M
SPDESpeedus Corp.HealthcareOTC$416
SZLSFStageZero Life Sciences Ltd.HealthcareOTC$61,766
TDSGFTelo Genomics Corp.HealthcareOTC$3.8M
TELO.VTelo Genomics Corp.HealthcareTSXV$4.0M
THOXFBioPorto A/SHealthcareOTC$73.8M
TMOThermo Fisher Scientific Inc.HealthcareNYSE$256.7B
ETFs holding Monash IVF Group Limited
TickerFundFund assets% of the fund
DISVDimensional - International Small Cap Value ETF$5.1B in assets0.01%
GWXState Street SPDR S&P International Small Cap ETF$882M in assets0.03%
DFISDimensional - International Small Cap ETF$5.8B in assets0.00%
DFAXDimensional - World ex US Core Equity 2 ETF$11.7B in assets0.00%
DFICDimensional - International Core Equity 2 ETF$15.4B in assets0.00%

Largest holders first, then the funds most concentrated in MVF.AX.

Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Monash IVF Group Limited.

MVF.AX AnalysisFair
Past
1
Growth
4
Health
3
Profit
1
Value
1